Niall Mahon

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients

Perry Elliott, Jan Poloniecki, Shaughan Dickie et al. · Journal of the American College of Cardiology · 2000 · 983 citations

Medicine, Cardiology, Internal Medicine +14

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 880 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 756 citations · Full text

Medicine, Cardiology, Pharmacology +13

Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy

Perry Elliott, Juan R. Gimeno, Niall Mahon et al. · The Lancet · 2001 · 518 citations

Medicine, Cardiology, Internal Medicine +7

Working formulation for the standardization of definitions of infections in patients using ventricular assist devices

Margaret M. Hannan, Shahid Husain, Frauke Mattner et al. · The Journal of Heart and Lung Transplantation · 2011 · 370 citations

Public Health, Cardiology, Infectious Diseases +11